Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 36.36
+2.48 (7.32%)
Sep 1, 2026, 4:08 PM HKT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 79.51 billion as of September 1, 2026. Its market cap has increased by 111.96% in one year.
Market Cap
79.51B
Enterprise Value
75.90B
Revenue
6.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
36.36
ChartMarket Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 79.51B, an increase of 3,664.88%. That is a compound annual growth rate of 40.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 79.51B | 192.82% |
| Dec 31, 2025 | 27.15B | 28.72% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 203.05B |
| Innovent Biologics | 176.88B |
| Sichuan Kelun-Biotech Biopharmaceutical | 117.07B |
| Sino Biopharmaceutical | 93.68B |
| Akeso | 82.81B |
| RemeGen | 65.83B |
| Biocytogen Pharmaceuticals (Beijing) | 53.92B |
| 3SBio | 40.02B |